{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T19:53:41Z","timestamp":1659210821076},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,10,4]],"date-time":"2008-10-04T00:00:00Z","timestamp":1223078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1245\/s10434-008-0160-3","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T15:32:29Z","timestamp":1223047949000},"page":"3415-3421","source":"Crossref","is-referenced-by-count":9,"title":["Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment"],"prefix":"10.1245","volume":"15","author":[{"given":"Phuong L.","family":"Mai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica I.","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R.","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,4]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin 2008; 58:71\u201396","journal-title":"CA Cancer J Clin"},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1073\/pnas.85.9.3044","volume":"85","author":"B Newman","year":"1988","unstructured":"Newman B, Austin MA, Lee M, et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988; 85:3044\u20138","journal-title":"Proc Natl Acad Sci USA"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.279.12.915","volume":"279","author":"B Newman","year":"1998","unstructured":"Newman B, Mu H, Butler LM, et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998; 279:915\u201321","journal-title":"JAMA"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343:692\u20135","journal-title":"Lancet"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56:265\u201371","journal-title":"Am J Hum Genet"},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:1401\u20138","journal-title":"N Engl J Med"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62:676\u201389","journal-title":"Am J Hum Genet"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002; 94:1365\u201372","journal-title":"J Natl Cancer Inst"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643\u20136","journal-title":"Science"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004; 22:2328\u201335","journal-title":"J Clin Oncol"},{"key":"160_CR11","doi-asserted-by":"crossref","unstructured":"The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 1999; 91:1310\u20136","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/bjoc.2000.1239","volume":"83","author":"LC Verhoog","year":"2000","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, et al. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer 2000; 83:384\u20136","journal-title":"Br J Cancer"},{"key":"160_CR13","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63:6643\u201350","journal-title":"Cancer Res"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1572-0241.2005.40237.x","volume":"100","author":"IR Schreibman","year":"2005","unstructured":"Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100:476\u201390","journal-title":"Am J Gastroenterol"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004; 22:1055\u201362","journal-title":"J Clin Oncol"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WLJ, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345:159\u201364","journal-title":"N Engl J Med"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93:1633\u20137","journal-title":"J Natl Cancer Inst"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","volume":"19","author":"SK McDonnell","year":"2001","unstructured":"McDonnell SK, Schaid DJ, Myers JL, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 2001; 19:3938\u201343","journal-title":"J Clin Oncol"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a Cancer Research Network project. J Clin Oncol 2005; 23:4275\u201386","journal-title":"J Clin Oncol"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","volume":"180","author":"EA Peralta","year":"2000","unstructured":"Peralta EA, Ellenhorn JD, Wagman LD, et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 2000; 180:439\u201345","journal-title":"Am J Surg"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/14737140.7.8.1117","volume":"7","author":"T Tuttle","year":"2007","unstructured":"Tuttle T, Habermann E, Abraham A, et al. Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Rev Anticancer Ther 2007; 7:1117\u201322","journal-title":"Expert Rev Anticancer Ther"},{"key":"160_CR22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.amjsurg.2008.01.007","volume":"195","author":"G Quan","year":"2008","unstructured":"Quan G, Pommier SJ, Pommier RF. Incidence and outcomes of contralateral breast cancers. Am J Surg 2008; 195:645\u201350","journal-title":"Am J Surg"},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3322\/canjclin.45.5.263","volume":"45","author":"MM Bilimoria","year":"1995","unstructured":"Bilimoria MM, Morrow M. The woman at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin 1995; 45:263\u201378","journal-title":"CA Cancer J Clin"},{"key":"160_CR24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","volume":"6","author":"LL Montgomery","year":"1999","unstructured":"Montgomery LL, Tran KN, Heelan MC, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 1999; 6:546\u201352","journal-title":"Ann Surg Oncol"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10549-006-9423-5","volume":"104","author":"K Graves","year":"2007","unstructured":"Graves K, Peshkin B, Halbert C, et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 2007; 104:321\u20139","journal-title":"Breast Cancer Res Treat"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.sembd.2006.10.001","volume":"9","author":"DJ MacDonald","year":"2006","unstructured":"MacDonald DJ, Sand S, Kass FC, et al. The power of partnership: Extending comprehensive cancer center expertise in clinical cancer genetics to breast care in community centers. Semin Breast Dis 2006; 9:39\u201347","journal-title":"Semin Breast Dis"},{"key":"160_CR27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"FJ Couch","year":"1997","unstructured":"Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336:1409\u201315","journal-title":"N Engl J Med"},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002; 20:1480\u201390","journal-title":"J Clin Oncol"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998; 62:145\u201358","journal-title":"Am J Hum Genet"},{"key":"160_CR30","doi-asserted-by":"crossref","unstructured":"American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21:2397\u2013406","DOI":"10.1200\/JCO.2003.03.189"},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","volume":"13","author":"P Broet","year":"1995","unstructured":"Broet P, de la Rochefordiere A, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 1995; 13:1578\u201383","journal-title":"J Clin Oncol"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1245\/s10434-007-9447-z","volume":"14","author":"A Giuliano","year":"2007","unstructured":"Giuliano A, Boolbol S, Degnim A, et al. Society of Surgical Oncology: Position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol 2007; 14:2425\u20137","journal-title":"Ann Surg Oncol"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 2007; 25:5203\u20139","journal-title":"J Clin Oncol"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/sj.bjc.6600988","volume":"88","author":"S Dijk van","year":"2003","unstructured":"van Dijk S, Otten W, Zoeteweij MW, et al. Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment. Br J Cancer 2003; 88:1675\u201381","journal-title":"Br J Cancer"},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.1994.423","volume":"70","author":"DG Evans","year":"1994","unstructured":"Evans DG, Blair V, Greenhalgh R, et al. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994; 70:934\u20138","journal-title":"Br J Cancer"},{"key":"160_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<413::AID-CNCR9>3.0.CO;2-S","volume":"80","author":"NC Dolan","year":"1997","unstructured":"Dolan NC, Lee AM, McDermott MM. Age-related differences in breast carcinoma knowledge, beliefs, and perceived risk among women visiting an academic general medicine practice. Cancer 1997; 80:413\u201320","journal-title":"Cancer"},{"key":"160_CR37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jnci\/87.10.720","volume":"87","author":"WC Black","year":"1995","unstructured":"Black WC, Nease RF Jr, Tosteson ANA. Perceptions of breast cancer risk and screening effectiveness in women younger than 50\u00a0years of age. J Natl Cancer Inst 1995; 87:720\u201331","journal-title":"J Natl Cancer Inst"},{"key":"160_CR38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jnci\/87.4.286","volume":"87","author":"C Lerman","year":"1995","unstructured":"Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995; 87:286\u201392","journal-title":"J Natl Cancer Inst"},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-8628(19990319)83:3<157::AID-AJMG4>3.0.CO;2-G","volume":"83","author":"MK Cho","year":"1999","unstructured":"Cho MK, Sankar P, Wolpe PR, et al. Commercialization of BRCA1\/2 testing: Practitioner awareness and use of a new genetic test. Am J Med Genet 1999; 83:157\u201363","journal-title":"Am J Med Genet"},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199601183340311","volume":"334","author":"FS Collins","year":"1996","unstructured":"Collins FS. BRCA1\u2014Lots of mutations, lots of dilemmas. N Engl J Med 1996; 334:186\u20138","journal-title":"N Engl J Med"},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"ASCO.","year":"2003","unstructured":"ASCO. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21:2397\u2013406","journal-title":"J Clin Oncol"},{"key":"160_CR42","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","volume":"24","author":"JG Guillem","year":"2006","unstructured":"Guillem JG, Wood WC, Moley JF, et al. ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 2006; 24:4642\u201360","journal-title":"J Clin Oncol"},{"key":"160_CR43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.6004\/jnccn.2006.0016","volume":"4","author":"MB Daly","year":"2006","unstructured":"Daly MB, Axilbund JE, Bryant E, et al. Genetic\/Familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 2006; 4:156\u201376","journal-title":"J Natl Compr Canc Netw"},{"key":"160_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jncimonographs\/lgi038","volume":"35","author":"L Nekhlyudov","year":"2005","unstructured":"Nekhlyudov L, Bower M, Herrinton LJ, et al. Women\u2019s decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005; 35:55\u201360","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-0160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-008-0160-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-0160-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:29:44Z","timestamp":1572971384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-008-0160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,4]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1245\/s10434-008-0160-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,4]]}}}